Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABRAFENIB vs DABRAFENIB\TRAMETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABRAFENIB vs DABRAFENIB\TRAMETINIB: Safety Overview

Metric DABRAFENIB DABRAFENIB\TRAMETINIB
Total FAERS Reports 19,305 113
Deaths Reported 4,165 10
Death Rate 21.6% 8.8%
Hospitalizations 5,325 17
Average Patient Age 58.3 yrs 55.1 yrs
% Female Patients 48.0% 49.5%
FDA Approval Date Mar 16, 2023 N/A
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route ORAL N/A
Marketing Status Prescription N/A